Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 2.0T | 1.9T | 2.1T | 1.9T |
Cost of revenue | 1.6T | 1.6T | 1.7T | 1.6T |
Gross profit | 330.6B | 311.2B | 415.4B | 317.4B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 212.1B | 213.2B | 235.8B | 200.5B |
Other operating expenses | 25.3B | 18.4B | 84.2B | 47.5B |
Operating income | 93.2B | 79.6B | 212.9B | 69.4B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 80.6B | 75.6B | 104.1B | 57.3B |
Tax provision | 24.9B | 22.4B | 19.5B | 19.0B |
Net income | 55.7B | 53.1B | 84.5B | 38.3B |
Basic EPS | 4.3 | 3.7 | — | 2.4 |
Diluted EPS | 4.3 | 3.7 | — | 2.4 |
Basic average shares | 12.2B | 12.2B | — | 12.2B |
Diluted average shares | 12.2B | 12.2B | — | 12.2B |
EBITDA | 294.9B | 278.9B | 388.0B | 267.1B |
Net income from continuing op. | 80.6B | 75.6B | 104.1B | 59.5B |
Minority interests | 1.1B | -5.0B | -4.6B | -5.1B |
Preferred stock dividends | 3.9B | 3.7B | 3.8B | 3.7B |